XenoPort, Inc. (NASDAQ: XNPT) announced today that, subject to the approval of the U.S. Food and Drug Administration (FDA), the ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE